MBR Team Brendan Jordan, M.E. & M.I. Systems Support Manager - - PowerPoint PPT Presentation

mbr team
SMART_READER_LITE
LIVE PREVIEW

MBR Team Brendan Jordan, M.E. & M.I. Systems Support Manager - - PowerPoint PPT Presentation

MBR Development Using Offsite MBR Team Brendan Jordan, M.E. & M.I. Systems Support Manager Pfizer Grange Castle. Pfizer in Ireland Over 3,200 people employed. Six locations around Ireland. $7 billion in Ireland over the past decade .


slide-1
SLIDE 1

MBR Development Using Offsite MBR Team

Brendan Jordan, M.E. & M.I. Systems Support Manager Pfizer Grange Castle.

slide-2
SLIDE 2

Pfizer in Ireland

Over 3,200 people employed. Six locations around Ireland. $7 billion in Ireland over the past decade.

slide-3
SLIDE 3

1999-2003: Engineering and building construction 2003: Pfizer Grange Castle opened to colleagues 2005: Grange Castle’s official opening 2009: Grange Castle joins Pfizer

Grange Castle: 2000-Today

slide-4
SLIDE 4

Site Overview

Suite 3: Syringe Fill/ Finish PREVENAR 13 MnB Quality Control Labs Warehouse Drug Substance (ENBREL DS) Development

90-acre site • 1.1 million sq. ft buildings

Utilities Building Admin

“Grange Castle will lead the world in Biotech Product Supply through competitiveness, flexibility and compliance.”

GC Vision

Suite 1 & Suite 2: Vaccine Conjugation PREVENAR 13 Suite 4

(Pegylation/Conjugation) SOMAVERT

& Suite 5

(Multi-purpose Conjugation) (CTM)

slide-5
SLIDE 5

Scope of MES implementation

  • Scope of MES implementation at GC

– Objective was to implement fully paperless batch recording and Review by Exception. – Integration with other systems:

  • SAP for Order Recipes, BOMs, material consumption etc.
  • MCS and SCADA controlled Equipment for batch load, GMP

alarm recording & OPC Reads.

  • LIMS for recording of QC test results in eBR.
  • bench top equipment e.g. Scales, pH meters for reading of

analytical results.

  • PDOCS – hyperlinks to SOP’s.
slide-6
SLIDE 6

Timeline of MES at G.C.

Proteins 1st Project (In-house) Vaccines S2 2nd Project (Out-sourced) Parenterals 3rd Project (In-House) Vaccines S1 4th Project (Out-sourced)

slide-7
SLIDE 7

Initial Deployment of MES

  • MES: PMX at GC.

– Wyeth/Pfizer Corporate MES solution

  • Scope of first project:

– Infrastructure and Application deployed and qualified. – pBRs replaced with eMBRs. – EQO’s to replace primary equipment logbooks.

  • Large Project - completed in-house:

– Made use of MES Contract resources from automation companies. – Basis for further collaboration.

slide-8
SLIDE 8

1st Out-Sourced Project

  • In 2010 Pfizer committed $200m investment to

GC to expand Manufacturing Capacity at the Site.

– Included construction of a new Vaccines Manufacturing Suite. – Transfer of processes from the USA to GC. – Decision was made to bring the Suite up on MES.

slide-9
SLIDE 9

1st Out-Sourced Project

  • Three Automation houses were requested to

quote for a Fixed Price contract.

– Requirements based on paper Batch Records – Bid based on their assessment of the work involved. – A preferred bidder was selected. Detailed negotiations led to an award of a contract. – Selection of bidder based on:

  • A good working relationship existed
  • Price
  • Location
slide-10
SLIDE 10

Project Organisation

Project Manager EBR Author 1 EBR Author 2 Operations 1 Operations 2 Quality 1

GC Site Based Team

Full-Time

PMX Admin SAP Admin

Supply Chain

Ops Readiness Auto- mation

Part-Time

Project Manager EBR Author 1 EBR Author 2 Quality

Vendor Team

EBR Author 3 EBR Author 3

slide-11
SLIDE 11

MBR Build Process

slide-12
SLIDE 12

Outcome

  • eMBRs went live in 2012
  • Overall a successful project:

– On time – Within budget – eMBRs were used for PV Batches for FDA Filing – Suite underwent a successful IMB Inspection in January.

  • Provided valuable lessons to the Site on the
  • utsourced model.
slide-13
SLIDE 13

Lessons learned

  • GC did not provide Vendor with sufficient

guidelines on Build requirements:

  • Managing the iterative Build/Review process:
  • Managing Scope Creep.
  • Build Environment did not work well.
slide-14
SLIDE 14

2nd Out-Sourced Project.

  • In 2011 decision made to replace pBRs in

existing Vaccines Suite with eMBRs.

  • Same Vendor was asked to price this work:

– Similar processes to first project. – First project was successful. – Possibility to leverage some of the First Build. – Relationship with Vendor had grown stronger.

slide-15
SLIDE 15

2nd Out-Sourced Project.

  • Changes to process made based on lessons

learned from S2 implementation:

– URS + Guideline Document. – Vendor given remote access to Prod Env. – Vendor eMBR Authors trained in Site Procedures. – Agreed the Vendor Authors who would do the Builds. – Used same team who had worked on first project.

slide-16
SLIDE 16

Improved MBR Build Process

slide-17
SLIDE 17

Outcome

  • eMBRs went Live in December 2013.

– Completed in 12 months. – Most efficient deployment to date. – Excellent Project. – Feedback from End Users has been very positive.

slide-18
SLIDE 18

Summary

  • Using an Off-Site Team worked well for G.C.
  • The Model improved over time:

– Relationship with the Vendor is important. – Requires trust and co-operation on both sides. – Significant amount of work still done in-house:

  • Review and approval of designs
  • Updates post FAT/PPT.
  • Final testing (P.T.) and the Go-Live process.
  • Further improvements possible.
slide-19
SLIDE 19

Thank You.

THANK YOU! QUESTIONS